Title:
TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
Document Type and Number:
WIPO Patent Application WO/2022/156757
Kind Code:
A1
Abstract:
It relates to tricyclic compounds, pharmaceutically acceptable compositions comprising the tricyclic compounds and methods of using said compositions in the treatment of various disorders.
Inventors:
HAN YING (CN)
LI DAPENG (CN)
LONG HUAJUN (CN)
WANG TONG (CN)
YIN ZHIYU (CN)
WANG YU (CN)
LI DAPENG (CN)
LONG HUAJUN (CN)
WANG TONG (CN)
YIN ZHIYU (CN)
WANG YU (CN)
Application Number:
PCT/CN2022/073097
Publication Date:
July 28, 2022
Filing Date:
January 21, 2022
Export Citation:
Assignee:
JINGRUI BIOPHARMA CO LTD (CN)
International Classes:
C07D471/14; A61K31/437; A61P35/00
Domestic Patent References:
WO2020001152A1 | 2020-01-02 | |||
WO2019080941A1 | 2019-05-02 | |||
WO2017133681A1 | 2017-08-10 | |||
WO2017124936A1 | 2017-07-27 | |||
WO2016183115A1 | 2016-11-17 | |||
WO2015100282A1 | 2015-07-02 |
Foreign References:
US20160333013A1 | 2016-11-17 | |||
US20170327498A1 | 2017-11-16 | |||
US20180127413A1 | 2018-05-10 | |||
US20180036294A1 | 2018-02-08 |
Attorney, Agent or Firm:
WU, FENG & ZHANG (CN)
Download PDF:
Previous Patent: ROADSIDE TERMINAL, TRAFFIC LIGHT CONTROL METHOD, AND RELATED SYSTEM
Next Patent: NOVEL AMIDE PYRROLE COMPOUND AND USE THEREOF IN DRUGS
Next Patent: NOVEL AMIDE PYRROLE COMPOUND AND USE THEREOF IN DRUGS